Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity. Jones JL, Anderson JM, Phuah C-L, Fox EJ, Selmaj K, Margolin D, Lake SL, Palmer J, Thompson SJ, Wilkins A, et al. Brain. 2010 Aug; 133(Pt 8):2232-47. Epub 2010 Jul 21. PMID: 20659956. Abstract CommentRecommendBookmarkWatch